[Basis of gestagen therapy of endometrial carcinoma].
D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000627:therapeutic use; D009277:Nandrolone / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D011372:Progestins / Q000009:adverse effects / Q000627:therapeutic use*; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D012075:Remission, Spontaneous; D014594:Uterine Neoplasms / Q000032:analysis / Q000188:drug therapy*
D006908:Hydroxyprogesterones; D011372:Progestins; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D009277:Nandrolone
Grundlagen der Gestagentherapie des Endometriumkarzinoms.